Erratum: Seroprevalence of human betaretrovirus surface protein antibodies in patients with breast cancer and liver disease (Journal of Oncology (2020) 2020:9 (8958192) DOI: 10.1155/2020/8958192)

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the article titled “Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease” [1], a sentence in Section 2.2 was incorrect. The sentence “A serum panel of breast cancer patients (n = 98) and age/sex-matched controls (n = 102) was obtained from the Alberta Tomorrow Project, a longitudinal study tracking 55,000 adults in Alberta” should be corrected to “A serum panel of breast cancer patients (n = 98) and age/ sex-matched controls (n = 102) was obtained from the breast cancer outpatient clinic Cross Cancer Institute.” The authors also wish to acknowledge an additional funding body. The modified Acknowledgments section is as follows.

Cite

CITATION STYLE

APA

Zhang, G., Bashiri, K., Kneteman, M., Cave, K., Hong, Y., Mackey, J. R., … Mason, A. L. (2020). Erratum: Seroprevalence of human betaretrovirus surface protein antibodies in patients with breast cancer and liver disease (Journal of Oncology (2020) 2020:9 (8958192) DOI: 10.1155/2020/8958192). Journal of Oncology. Hindawi Limited. https://doi.org/10.1155/2020/7406146

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free